Neonatal stroke

Neonatal stroke, similar to a stroke which occurs in adults, is defined as a disturbance to the blood supply of the developing brain in the first 28 days of life.[1] This description includes both ischemic events, which results from a blockage of vessels, and hypoxic events, which results from a lack of oxygen to the brain tissue, as well as some combination of the two.[2][3] One treatment with some proven benefits is hypothermia, but may be most beneficial in conjunction with pharmacological agents.[4] Well-designed clinical trials for stroke treatment in neonates are lacking, but some current studies involve the transplantation of neural stem cells and umbilical cord stem cells; it is not yet known if this therapy is likely to be successful.[4]

Neonatal strokes may lead to cerebral palsy, learning difficulties, or other disabilities.[5] A neonatal stroke occurs in approximately 1 in 4000 births, but is likely much higher due to the lack of noticeable symptoms.[1]

  1. ^ a b Aden, U. (2009). Neonatal Stroke Is Not a Harmless Condition. Stroke, 40, 1948-1949. doi:10.1161/STROKEAHA.109.550152.
  2. ^ Sehgal, A. (2011). Perinatal Stroke: a case-based review. European Journal of Pediatrics. doi:10.1007/s00431-011-1509-3.
  3. ^ Derugin, N., Ferriero, D. M., Vexler, Z. S. (1998) Neonatal reversible focal cerebral ischemia: a new model. Neuroscience Research 32, 349-353.
  4. ^ a b Rees, S., Harding, R., Walker, D. (2011). The biological basis of injury and neuroprotection in the fetal and neonatal brain. International Journal of Developmental Neuroscience, 29, 551-563.
  5. ^ Chauvier, D., Renolleau, S., Holifanjaniaina, S., Ankri, S., Bezault, M., Schwendimann, L., et al. (2011). Targeting neonatal ischemic brain injury with a pentapeptide-based irreversible caspase inhibitor. Cell Death & Disease, 2, 203. doi:10.1038/cddis.2011.87.